Dassault Systemes SE Life Sciences Day Transcript
§-© - ¨--
Good afternoon, for the ones on the webcast. I'm François-José Bordonado, Dassault Systèmes, from the Investor Relations team. From the company, we have, for this first Life Sciences Day in New York, Bernard Charlès, our Vice Chairman and CEO; Pascal Daloz, Dassault Systèmes CFO and Chief Strategy Officer; Tarek Sherif and Glen De Vries, Medidata's founders and co-CEOs; Rouven Bergmann, Medidata's Chief Operating Officer; Claire Biot, VP, Life Sciences; and Jason Benedict, BIOVIA VP, R&D. I would like to welcome you to Dassault Systèmes Life Sciences Day.
At the end of the presentation, as you see in the agenda on the screen, we'll take questions from the audience. Please note some of the comments we'll make during today's presentation will contain forward-looking statements, which could differ materially from actual results. Please refer to our risk factors in our 2018 document referrals. Let me now introduce Bernard
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |